Karen Wernli to Receptors, Estrogen
This is a "connection" page, showing publications Karen Wernli has written about Receptors, Estrogen.
Connection Strength
0.053
-
Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor-Positive Breast Cancer. J Clin Oncol. 2023 Feb 01; 41(4):859-870.
Score: 0.053